The 2021 bull market for medtech investment cooled in 2022 as inflation and economic uncertainty left investors with less capital.
Despite the market slowdown, 2022 investment numbers still outperformed pre-COVID-19 pandemic investment figures, as 2019 saw $59.7 billion raised.
